ReCode Therapeutics appoints Dean Mitchell as Chairman of its Board of Directors
– USA, CA – ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, today announced the appointment of Dean Mitchell as Chairman of its Board of Directors.…